Conventional Postoperative Radiotherapy (Standard Fractionation) Plus Iressa [gefitinib] or Hyperfractionated Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer: A Phase I Pilot Trial
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2010
At a glance
- Drugs Cisplatin; Gefitinib
- Indications Head and neck cancer
- Focus Adverse reactions
- 21 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2008 New trial record.